Modulation of estrogen synthesis and metabolism by phytoestrogens: In vitro and the implications for women's health

Toxicology Research

Volumn 6, Issue 6, 2017, Pages 772-794

  Van Duursen, Majorie B M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

8 PRENYLNARINGENIN; BIOCHANIN A; DAIDZEIN; ESTROGEN RECEPTOR; GENISTEIN; NARINGENIN; PHYTOESTROGEN; QUERCETIN; RESVERATROL;

ESTROGEN BLOOD LEVEL; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; FEMALE; HUMAN; IN VITRO STUDY; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SUPPLEMENTATION; TISSUE LEVEL; WOMEN'S HEALTH;

EID: 85032615313     PISSN: 2045452X     EISSN: 20454538     Source Type: Journal    
DOI: 10.1039/c7tx00184c     Document Type: Review

References (213)

1. A. R. War M. G. Paulraj T. Ahmad A. A. Buhroo B. Hussain S. Ignacimuthu H. C. Sharma Mechanisms of plant defense against insect herbivores Plant Signaling Behav. 2012 7 1306 1320
2. B. M. Dietz A. Hajirahimkhan T. L. Dunlap J. L. Bolton Botanicals and Their Bioactive Phytochemicals for Women's Health Pharmacol. Rev. 2016 68 1026 1073
3. T. Cornwell W. Cohick I. Raskin Dietary phytoestrogens and health Phytochemistry 2004 65 995 1016
4. M. S. Touillaud P. C. Pillow J. Jakovljevic M. L. Bondy S. E. Singletary D. Li S. Chang Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer Nutr. Cancer 2005 51 162 169
5. C. R. Sirtori A. Arnoldi S. K. Johnson Phytoestrogens: end of a tale? Ann. Med. 2005 37 423 438
6. H. Adlercreutz Phyto-oestrogens and cancer Lancet Oncol. 2002 3 364 373
7. P. Posadzki M. S. Lee T. W. Moon T. Y. Choi T. Y. Park E. Ernst Prevalence of complementary and alternative medicine (CAM) use by menopausal women: a systematic review of surveys Maturitas 2013 75 34 43
8. P. B. Yazbek J. Tezoto F. Cassas E. Rodrigues Plants used during maternity, menstrual cycle and other women's health conditions among Brazilian cultures J. Ethnopharmacol. 2016 179 310 331
9. A. Garcia-Alvarez B. Egan S. de Klein L. Dima F. M. Maggi M. Isoniemi L. Ribas-Barba M. M. Raats E. M. Meissner M. Badea F. Bruno M. Salmenhaara R. Mila-Villarroel V. Knaze C. Hodgkins A. Marculescu L. Uusitalo P. Restani L. Serra-Majem Usage of plant food supplements across six European countries: findings from the PlantLIBRA consumer survey PLoS One 2014 9 e92265
10. T. Smith K. Kawa V. Eckl J. S. Johnson Sales of herbal dietary supplements in US increased 7.5% in 2015. HerbalGram 2016 111 67 73
11. B. Jiang C. Ma T. Motley F. Kronenberg E. J. Kennelly Phytochemical fingerprinting to thwart black cohosh adulteration: a 15 Actaea species analysis Phytochem. Anal. 2011 22 339 351
12. L. Q. Wang Mammalian phytoestrogens: enterodiol and enterolactone J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2002 777 289 309
13. N. G. Coldham M. J. Sauer Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement Food Chem. Toxicol. 2001 39 1211 1224
14. M. B. van Duursen E. E. Smeets J. C. Rijk S. M. Nijmeijer M. van den Berg Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model Toxicol. Appl. Pharmacol. 2013 269 132 140
15. M. Imhof S. Molzer M. Imhof Effects of soy isoflavones on 17beta-estradiol-induced proliferation of MCF-7 breast cancer cells Toxicol. in Vitro 2008 22 1452 1460
16. H. B. Patisaul W. Jefferson The pros and cons of phytoestrogens Front. Neuroendocrinol. 2010 31 400 419
17. S. Bolca M. Urpi-Sarda P. Blondeel N. Roche L. Vanhaecke S. Possemiers N. Al-Maharik N. Botting D. De Keukeleire M. Bracke A. Heyerick C. Manach H. Depypere Disposition of soy isoflavones in normal human breast tissue Am. J. Clin. Nutr. 2010 91 976 984
18. Y. J. Moon L. Wang R. DiCenzo M. E. Morris Quercetin pharmacokinetics in humans Biopharm. Drug Dispos. 2008 29 205 217
19. P. de Cremoux P. This G. Leclercq Y. Jacquot Controversies concerning the use of phytoestrogens in menopause management: bioavailability and metabolism Maturitas 2010 65 334 339
20. T. Ozdal D. A. Sela J. Xiao D. Boyacioglu F. Chen E. Capanoglu The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility Nutrients 2016 8 78
21. K. D. Setchell N. M. Brown L. Zimmer-Nechemias W. T. Brashear B. E. Wolfe A. S. Kirschner J. E. Heubi Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability Am. J. Clin. Nutr. 2002 76 447 453
22. I. R. Rowland H. Wiseman T. A. Sanders H. Adlercreutz E. A. Bowey Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora Nutr. Cancer 2000 36 27 32
23. K. D. Setchell N. M. Brown P. Desai L. Zimmer-Nechemias B. E. Wolfe W. T. Brashear A. S. Kirschner A. Cassidy J. E. Heubi Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements J. Nutr. 2001 131 1362S 1375S
24. R. Boonpawa N. Moradi A. Spenkelink I. M. Rietjens A. Punt Use of physiologically based kinetic (PBK) modeling to study interindividual human variation and species differences in plasma concentrations of quercetin and its metabolites Biochem. Pharmacol. 2015 98 690 702
25. M. Rad M. Humpel O. Schaefer R. C. Schoemaker W.-D. Schleuning A. F. Cohen J. Burggraaf Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women Br. J. Clin. Pharmacol. 2006 62 288 296
26. L. Almeida M. Vaz-da-Silva A. Falcao E. Soares R. Costa A. I. Loureiro C. Fernandes-Lopes J. F. Rocha T. Nunes L. Wright P. Soares-da-Silva Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers Mol. Nutr. Food Res. 2009 53 Suppl 1 S7 15
27. Z. Yang K. Kulkarni W. Zhu M. Hu Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME Anticancer Agents Med. Chem. 2012 12 1264 1280
28. J. Maubach H. T. Depypere J. Goeman J. Van der Eycken A. Heyerick M. E. Bracke P. Blondeel D. De Keukeleire Distribution of soy-derived phytoestrogens in human breast tissue and biological fluids Obstet. Gynecol. 2004 103 892 898
29. J. Enokizono H. Kusuhara Y. Sugiyama Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens Mol. Pharmacol. 2007 72 967 975
30. K. W. Tan J. Cooney D. Jensen Y. Li J. W. Paxton N. P. Birch A. Scheepens Hop-derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein (BCRP/ABCG2) Mol. Nutr. Food Res. 2014 58 2099 2110
31. S. Bolca J. Li D. Nikolic N. Roche P. Blondeel S. Possemiers D. De Keukeleire M. Bracke A. Heyerick R. B. van Breemen H. Depypere Disposition of hop prenylflavonoids in human breast tissue Mol. Nutr. Food Res. 2010 54 Suppl 2 S284 S294
32. W. Wang W. Zhang J. Liu Y. Sun Y. Li H. Li S. Xiao X. Shen Metabolomic changes in follicular fluid induced by soy isoflavones administered to rats from weaning until sexual maturity Toxicol. Appl. Pharmacol. 2013 269 280 289
33. J. Howes M. Waring L. Huang L. G. Howes Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense) J. Altern. Complement. Med. 2002 8 135 142
34. I. Erlund E. Meririnne G. Alfthan A. Aro Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice J. Nutr. 2001 131 235 241
35. F. I. Kanaze M. I. Bounartzi M. Georgarakis I. Niopas Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects Eur. J. Clin. Nutr. 2007 61 472 477
36. C. Sergides M. Chirila L. Silvestro D. Pitta A. Pittas Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers Exp. Ther. Med. 2016 11 164 170
37. A. Burkon V. Somoza Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides-two novel resveratrol metabolites in human plasma Mol. Nutr. Food Res. 2008 52 549 557
38. D. Kaushik K. O'Fallon P. M. Clarkson C. P. Dunne K. R. Conca B. Michniak-Kohn Comparison of quercetin pharmacokinetics following oral supplementation in humans J. Food Sci. 2012 77 H231 H238
39. A. Csiszar Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease Ann. N. Y. Acad. Sci. 2011 1215 117 122
40. M. B. Ruiz-Larrea A. R. Mohan G. Paganga N. J. Miller G. P. Bolwell C. A. Rice-Evans Antioxidant activity of phytoestrogenic isoflavones Free Radical Res. 1997 26 63 70
41. H. S. Lee Z. Herceg The epigenome and cancer prevention: A complex story of dietary supplementation Cancer Lett. 2014 342 275 284
42. Y. W. Huang C. T. Kuo K. Stoner T. H. Huang L. S. Wang An overview of epigenetics and chemoprevention FEBS Lett. 2011 585 2129 2136
43. G. R. Yan C. L. Xiao G. W. He X. F. Yin N. P. Chen Y. Cao Q. Y. He Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways Proteomics 2010 10 976 986
44. D. Toft J. Gorski A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization Proc. Natl. Acad. Sci. U. S. A. 1966 55 1574 1581
45. G. G. Kuiper E. Enmark M. Pelto-Huikko S. Nilsson J. A. Gustafsson Cloning of a novel receptor expressed in rat prostate and ovary Proc. Natl. Acad. Sci. U. S. A. 1996 93 5925 5930
46. C. Thomas J. A. Gustafsson The different roles of ER subtypes in cancer biology and therapy Nat. Rev. Cancer 2011 11 597 608
47. S. M. Cowley M. G. Parker A comparison of transcriptional activation by ER alpha and ER beta J. Steroid Biochem. Mol. Biol. 1999 69 165 175
48. G. G. Kuiper J. G. Lemmen B. Carlsson J. C. Corton S. H. Safe P. T. van der Saag B. van der Burg J. A. Gustafsson Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 1998 139 4252 4263
49. I. M. Rietjens J. Louisse K. Beekmann The potential health effects of dietary phytoestrogens Br. J. Pharmacol. 2016 174 1263 1280
50. T. F. Bovee R. J. Helsdingen I. M. Rietjens J. Keijer R. L. Hoogenboom Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types J. Steroid Biochem. Mol. Biol. 2004 91 99 109
51. E. Reiter E. Reiter V. Beck S. Medjakovic A. Jungbauer Isoflavones are safe compounds for therapeutical applications-evaluation of in vitro data Gynecol. Endocrinol. 2009 25 554 580
52. F. Roelens N. Heldring W. Dhooge M. Bengtsson F. Comhaire J. A. Gustafsson E. Treuter D. De Keukeleire Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta J. Med. Chem. 2006 49 7357 7365
53. S. Milligan J. Kalita V. Pocock A. Heyerick L. De Cooman H. Rong D. De Keukeleire Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin Reproduction 2002 123 235 242
54. O. Schaefer M. Humpel K. H. Fritzemeier R. Bohlmann W. D. Schleuning 8-Prenyl naringenin is a potent ERalpha selective phytoestrogen present in hops and beer J. Steroid Biochem. Mol. Biol. 2003 84 359 360
55. J. A. van Meeuwen N. Korthagen P. C. de Jong A. H. Piersma M. van den Berg (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture Toxicol. Appl. Pharmacol. 2007 221 372 383
56. Y. Shang M. Brown Molecular determinants for the tissue specificity of SERMs Science 2002 295 2465 2468
57. J. A. van Meeuwen W. Ter Burg A. H. Piersma M. van den Berg J. T. Sanderson Mixture effects of estrogenic compounds on proliferation and pS2 expression of MCF-7 human breast cancer cells Food Chem. Toxicol. 2007 45 2319 2330
58. J. A. van Meeuwen M. van den Berg J. T. Sanderson A. Verhoef A. H. Piersma Estrogenic effects of mixtures of phyto- and synthetic chemicals on uterine growth of prepubertal rats Toxicol. Lett. 2007 170 165 176
59. E. J. Filardo P. Thomas Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology Endocrinology 2012 153 2953 2962
60. E. R. Prossnitz M. Barton The G-protein-coupled estrogen receptor GPER in health and disease Nat. Rev. Endocrinol. 2011 7 715 726
61. E. R. Prossnitz J. B. Arterburn International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators Pharmacol. Rev. 2015 67 505 540
62. N. Filigheddu S. Sampietro F. Chianale P. E. Porporato M. Gaggianesi I. Gregnanin E. Rainero M. Ferrara B. Perego F. Riboni G. Baldanzi A. Graziani N. Surico Diacylglycerol kinase alpha mediates 17-beta-estradiol-induced proliferation, motility, and anchorage-independent growth of Hec-1A endometrial cancer cell line through the G protein-coupled estrogen receptor GPR30 Cell. Signalling 2011 23 1988 1996
63. C. Wang X. Lv C. He G. Hua M. Y. Tsai J. S. Davis The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization Cell Death Dis. 2013 4 e869
64. E. A. Ariazi E. Brailoiu S. Yerrum H. A. Shupp M. J. Slifker H. E. Cunliffe M. A. Black A. L. Donato J. B. Arterburn T. I. Oprea E. R. Prossnitz N. J. Dun V. C. Jordan The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells Cancer Res. 2010 70 1184 1194
65. W. Wei Z. J. Chen K. S. Zhang X. L. Yang Y. M. Wu X. H. Chen H. B. Huang H. L. Liu S. H. Cai J. Du H. S. Wang The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo Cell Death Dis. 2014 5 e1428
66. F. Chen Q. Zhang T. McDonald M. J. Davidoff W. Bailey C. Bai Q. Liu C. T. Caskey Identification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCR Gene 1999 228 101 109
67. R. Kiyama Y. Wada-Kiyama Estrogenic endocrine disruptors: Molecular mechanisms of action Environ. Int. 2015 83 11 40
68. J. L. Jameson, L. J. De Groot, D. de Kretser, L. C. Giudice, A. Grossman, S. Melmed, J. T. Potts and G. C. Weir, Endocrinology: Adult and Pediatric, Elsevier Saunders, Philadelphia, PA, 7th edn, 2016
69. A. A. van Landeghem J. Poortman M. Nabuurs J. H. Thijssen Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue Cancer Res. 1985 45 2900 2906
70. W. L. Miller R. J. Auchus The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders Endocr. Rev. 2011 32 81 151
71. B. C. Chung J. Picado-Leonard M. Haniu M. Bienkowski P. F. Hall J. E. Shively W. L. Miller Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues Proc. Natl. Acad. Sci. U. S. A. 1987 84 407 411
72. M. Kagimoto J. S. Winter K. Kagimoto E. R. Simpson M. R. Waterman Structural characterization of normal and mutant human steroid 17 alpha-hydroxylase genes: molecular basis of one example of combined 17 alpha-hydroxylase/17,20 lyase deficiency Mol. Endocrinol. 1988 2 564 570
73. N. Tilson-Mallett S. J. Santner P. D. Feil R. J. Santen Biological significance of aromatase activity in human breast tumors J. Clin. Endocrinol. Metab. 1983 57 1125 1128
74. J. B. Adams K. Li Biosynthesis of 17beta-oestradiol in human breast carcinoma tissue and a novel method for its characterization Br. J. Cancer 1975 31 429 433
75. A. D. Nguyen A. J. Conley Adrenal androgens in humans and nonhuman primates: production, zonation and regulation Endocr. Dev. 2008 13 33 54
76. E. R. Simpson Sources of estrogen and their importance J. Steroid Biochem. Mol. Biol. 2003 86 225 230
77. J. Pasqualini G. Chetrite B. Nguyen C. Maloche L. Delalonde M. Talbi M. Feinstein C. Blacker J. Botella J. Paris Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence. J. Steroid Biochem. Mol. Biol. 1995 53 407 412
78. R. Raftogianis C. Creveling R. Weinshilboum J. Weisz Estrogen metabolism by conjugation. J. Natl. Cancer Inst. Monogr. 2000 27 113 124
79. L. Tseng J. Mazella L. Y. Lee M. L. Stone Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma J. Steroid Biochem. 1983 19 1413 1417
80. S. J. Santner D. Leszczynski C. Wright A. Manni P. D. Feil R. J. Santen Estrone sulfate: a potential source of estradiol in human breast cancer tissues Breast Cancer Res. Treat. 1986 7 35 44
81. C. P. Martucci J. Fishman P450 enzymes of estrogen metabolism Pharmacol. Ther. 1993 57 237 257
82. A. F. Badawi E. L. Cavalieri E. G. Rogan Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol Metabolism 2001 50 1001 1003
83. R. G. Ziegler S. C. Rossi T. R. Fears H. L. Bradlow H. Adlercreutz D. Sepkovic P. Kiuru K. Wahala J. B. Vaught J. L. Donaldson R. T. Falk C. M. Fillmore P. K. Siiteri R. N. Hoover M. H. Gail Quantifying estrogen metabolism: an evaluation of reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16a-hydroxyestrone in urine. Environ. Health Perspect. 1997 105 607 614
84. J. Weisz G. A. Clawson C. R. Crevelingen Biogenesis and inactivation of catecholestrogens. Adv. Pharmacol. 1998 42 828 833
85. R. T. Borchardt Catechol O-methyltransferase. Methods Enzymol. 1981 77 267 272
86. S. Dawling N. Roodi R. L. Mernaugh X. Wang F. F. Parl Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms Cancer Res. 2001 61 6716 6722
87. P. T. Männistö S. Kaakkola Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors Pharmacol. Rev. 1999 51 593 628
88. A. Kamat M. M. Hinshelwood B. A. Murry C. R. Mendelson Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans Trends Endocrinol. Metab. 2002 13 122 128
89. S. A. Chen M. J. Besman R. S. Sparkes S. Zollman I. Klisak T. Mohandas P. F. Hall J. E. Shively Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15 DNA 1988 7 27 38
90. E. R. Simpson C. Clyne G. Rubin W. C. Boon K. Robertson K. Britt C. Speed M. Jones Aromatase-a brief overview Annu. Rev. Physiol. 2002 64 93 127
91. E. R. Simpson M. D. Michael V. R. Agarwal M. M. Hinshelwood S. E. Bulun Y. Zhao Cytochromes P450 11: expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage FASEB J. 1997 11 29 36
92. S. E. Bulun Z. Lin G. Imir S. Amin M. Demura B. Yilmaz R. Martin H. Utsunomiya S. Thung B. Gurates M. Tamura D. Langoi S. Deb Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment Pharmacol. Rev. 2005 57 359 383
93. C. Stocco Aromatase expression in the ovary: hormonal and molecular regulation Steroids 2008 73 473 487
94. S. Ghosh Y. Wu R. Li Y. Hu Jun proteins modulate the ovary-specific promoter of aromatase gene in ovarian granulosa cells via a cAMP-responsive element Oncogene 2005 24 2236 2246
95. V. R. Agarwal S. E. Bulun M. Leitch R. Rohrich E. R. Simpson Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients J. Clin. Endocrinol. Metab. 1996 81 3843 3849
96. C. Zhou D. Zhou J. Esteban J. Murai P. K. Siiteri S. Wilczynski S. Chen Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction J. Steroid Biochem. Mol. Biol. 1996 59 163 171
97. J. Kitawaki T. Noguchi T. Amatsu K. Maeda K. Tsukamoto T. Yamamoto S. Fushiki Y. Osawa H. Honjo Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium Biol. Reprod. 1997 57 514 519
98. S. Taga N. Yoshida K. Sekiba Distribution and cyclic change of aromatase cytochrome P-450 activity in human uteri J. Steroid Biochem. Mol. Biol. 1990 37 741 745
99. J. Brosens H. Verhoeven R. Campo L. Gianaroli S. Gordts J. Hazekamp L. Hägglund T. Mardesic E. Varila J. Zech I. Brosens High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome Hum. Reprod. 2004 19 352 356
100. S. E. Bulun Z. Lin G. Imir S. Amin M. Demura B. Yilmaz R. Martin H. Utsunomiya S. Thung B. Gurates M. Tamura D. Langoi S. Deb Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment Pharmacol. Rev. 2005 57 359 383
101. E. D. Lephart Modulation of Aromatase by Phytoestrogens Enzyme Res. 2015 2015
102. 594656.
103. T. Gracia K. Hilscherova P. D. Jones J. L. Newsted X. Zhang M. Hecker E. B. Higley J. T. Sanderson R. M. K. Yu R. S. S. Wu J. P. Giesy The H295R system for evaluation of endocrine-disrupting effects Ecotoxicol. Environ. Saf. 2006 65 293 305
104. J. T. Sanderson J. Hordijk M. S. Denison M. F. Springsteel M. H. Nantz M. van den Berg Induction and Inhibition of Aromatase (CYP19) Activity by Natural and Synthetic Flavonoid Compounds in H295R Human Adrenocortical Carcinoma Cells Toxicol. Sci. 2004 82 70 79
105. J. D. Brooks L. U. Thompson Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells J. Steroid Biochem. Mol. Biol. 2005 94 461 467
106. S. Chottanapund M. B. Van Duursen P. Navasumrit P. Hunsonti S. Timtavorn M. Ruchirawat M. Van den Berg Anti-aromatase effect of resveratrol and melatonin on hormonal positive breast cancer cells co-cultured with breast adipose fibroblasts Toxicol. in Vitro 2014 28 1215 1221
107. Y. Wang K. W. Lee F. L. Chan S. Chen L. K. Leung The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells Toxicol. Sci. 2006 92 71 77
108. K. A. Solak F. Wijnolts S. M. Nijmeijer B. J. Blaauboer M. van den Berg M. B. M. van Duursen Excessive levels of phytoestrogens can modulate ovarian steroidogenesis and tumor progression in KGN human granulosa-derivded tumor cells. Toxicol. Rep. 2014 1 360 372
109. K. M. Edmunds A. C. Holloway D. J. Crankshaw S. K. Agarwal W. G. Foster The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells Reprod., Nutr., Dev. 2005 45 709 720
110. K. Sterzik C. Dallenbach V. Schneider V. Sasse G. Dallenbach-Hellweg In vitro fertilization: the degree of endometrial insufficiency varies with the type of ovarian stimulation Fertil. Steril. 1988 50 457 462
111. G. L. Rubin A. J. Harrold J. A. Mills C. N. Falany M. W. Coughtrie Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy Mol. Hum. Reprod. 1999 5 995 1002
112. T. L. Rizner The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases Front. Pharmacol. 2016 7 30
113. T. Suzuki T. Nakata Y. Miki C. Kaneko T. Moriya T. Ishida S. Akinaga H. Hirakawa M. Kimura H. Sasano Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma Cancer Res. 2003 63 2762 2770
114. H. Utsunomiya K. Ito T. Suzuki T. Kitamura C. Kaneko T. Nakata H. Niikura K. Okamura N. Yaegashi H. Sasano Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma Clin. Cancer Res. 2004 10 5850 5856
115. R. M. Harris D. M. Wood L. Bottomley S. Blagg K. Owen P. J. Hughes R. H. Waring C. J. Kirk Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment J. Clin. Endocrinol. Metab. 2004 89 1779 1787
116. S. Rice A. Amon S. A. Whitehead Ethanolic extracts of black cohosh (Actaea racemosa) inhibit growth and oestradiol synthesis from oestrone sulphate in breast cancer cells Maturitas 2007 56 359 367
117. Z. Huang M. J. Fasco L. S. Kaminsky Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids J. Steroid Biochem. Mol. Biol. 1997 63 9 15
118. C. E. Fluck W. L. Miller R. J. Auchus The 17, 20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway J. Clin. Endocrinol. Metab. 2003 88 3762 3766
119. P. Lee-Robichaud J. N. Wright M. E. Akhtar M. Akhtar Modulation of the activity of human 17 alpha-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications Biochem. J. 1995 308 Pt 3 901 908
120. A. H. Payne D. B. Hales Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones Endocr. Rev. 2004 25 947 970
121. A. H. Carey D. Waterworth K. Patel D. White J. Little P. Novelli S. Franks R. Williamson Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17 Hum. Mol. Genet. 1994 3 1873 1876
122. H. S. Feigelson L. S. Shames M. C. Pike G. A. Coetzee F. Z. Stanczyk B. E. Henderson Cytochrome P450c17{alpha} Gene (CYP17) Polymorphism Is Associated with Serum Estrogen and Progesterone Concentrations Cancer Res. 1998 58 585 587
123. A. Chakraborty N. S. Murthy C. Chintamani D. Bhatnagar R. S. Mohil P. C. Sharma S. Saxena CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients J. Hum. Genet. 2007 52 159 165
124. E. Verla-Tebit S. Wang-Gohrke J. Chang-Claude CYP17 5′-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study Breast Cancer Res. 2005 7 4 R455 R464
125. M. Henningson U. Johansson A. Borg H. Olsson H. Jernstro?m CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women Mol. Hum. Reprod. 2007 13 231 236
126. J. Little J. Simard CYP17 and breast cancer: No overall effect, but what about interactions? Breast Cancer Res. 2005 7 238 242
127. Y. Miyoshi A. Ando M. Ooka E. Shiba T. Taguchi Y. Tamaki S. Noguchi Association of CYP17 genetic polymorphism with intra-tumoral estradiol concentrations but not with CYP17 messenger RNA levels in breast cancer tissue Cancer Lett. 2003 195 81 86
128. J. K. Wickenheisser V. L. Nelson-DeGrave K. L. Hendricks R. S. Legro J. F. Strauss 3rd J. M. McAllister Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome J. Clin. Endocrinol. Metab. 2005 90 4858 4865
129. E. Hasegawa S. Nakagawa M. Sato E. Tachikawa S. Yamato Effect of polyphenols on production of steroid hormones from human adrenocortical NCI-H295R cells Biol. Pharm. Bull. 2013 36 228 237
130. F. K. Nielsen C. H. Hansen J. A. Fey M. Hansen N. W. Jacobsen B. Halling-Sorensen E. Bjorklund B. Styrishave H295R cells as a model for steroidogenic disruption: a broader perspective using simultaneous chemical analysis of 7 key steroid hormones Toxicol. in Vitro 2012 26 343 350
131. C. J. Lin L. C. Cheng T. C. Lin C. J. Wang L. A. Li Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation Biochem. Pharmacol. 2014 90 288 296
132. S. Gingras R. Moriggl B. Groner J. Simard Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13 Mol. Endocrinol. 1999 13 66 81
133. E. Rheaume Y. Lachance H. F. Zhao N. Breton M. Dumont Y. de Launoit C. Trudel V. Luu-The J. Simard F. Labrie Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads Mol. Endocrinol. 1991 5 1147 1157
134. N. Marti J. A. Galvan A. V. Pandey M. Trippel C. Tapia M. Muller A. Perren C. E. Fluck Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome Mol. Cell. Endocrinol. 2017 441 116 123
135. S. Ohno N. Matsumoto M. Watanabe S. Nakajin Flavonoid inhibition of overexpressed human 3β-hydroxysteroid dehydrogenase type II J. Steroid Biochem. Mol. Biol. 2004 88 175 182
136. M. Lacey J. Bohday S. M. Fonseka A. I. Ullah S. A. Whitehead Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells J. Steroid Biochem. Mol. Biol. 2005 96 279 286
137. S. Ohno S. Shinoda S. Toyoshima H. Nakazawa T. Makino S. Nakajin Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells J. Steroid Biochem. Mol. Biol. 2002 80 355 363
138. J. C. Le Bail Y. Champavier A. J. Chulia G. Habrioux Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells Life Sci. 2000 66 1281 1291
139. H. Peltoketo V. Luu-The J. Simard J. Adamski 17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes J. Mol. Endocrinol. 1999 23 1 11
140. F. Labrie V. Luu-The S. X. Lin C. Labrie J. Simard R. Breton A. Belanger The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology Steroids 1997 62 148 158
141. B. Han S. Li D. Song D. Poisson-Pare G. Liu V. Luu-The J. Ouellet S. Li F. Labrie G. Pelletier Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters J. Steroid Biochem. Mol. Biol. 2008 112 194 200
142. V. Luu-The I. Dufort G. Pelletier F. Labrie Type 5 17beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women Mol. Cell. Endocrinol. 2001 171 77 82
143. S. A. Whitehead M. Lacey Phytoestrogens inhibit aromatase but not 17beta-hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa-luteal cells: evidence for FSH induction of 17beta-HSD Hum. Reprod. 2003 18 487 494
144. S. Makela M. Poutanen M. L. Kostian N. Lehtimaki L. Strauss R. Santti R. Vihko Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells Proc. Soc. Exp. Biol. Med. 1998 217 310 316
145. D. Deluca A. Krazeisen R. Breitling C. Prehn G. Moller J. Adamski Inhibition of 17beta-hydroxysteroid dehydrogenases by phytoestrogens: comparison with other steroid metabolizing enzymes J. Steroid Biochem. Mol. Biol. 2005 93 285 292
146. A. Krazeisen R. Breitling G. Moller J. Adamski Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5 Mol. Cell. Endocrinol. 2001 171 151 162
147. J. R. Pasqualini Estrogen sulfotransferases in breast and endometrial cancers Ann. N. Y. Acad. Sci. 2009 1155 88 98
148. T. Nishiyama K. Ogura H. Nakano T. Kaku E. Takahashi Y. Ohkubo K. Sekine A. Hiratsuka S. Kadota T. Watabe Sulfation of environmental estrogens by cytosolic human sulfotransferases Drug Metab. Pharmacokinet. 2002 17 221 228
149. Y. Otake A. L. Nolan U. K. Walle T. Walle Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells J. Steroid Biochem. Mol. Biol. 2000 73 265 270
150. Y. Chen C. Huang T. Zhou G. Chen Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells Basic Clin. Pharmacol. Toxicol. 2008 103 553 559
151. C. R. Jefcoate J. G. Liehr R. J. Santen T. R. Sutter J. D. Yager W. Yue S. J. Santner R. Tekmal L. Demers R. Pauley F. Naftolin G. Mor L. Berstein Tissue-specific synthesis and oxidative metabolism of estrogens. J. Natl. Cancer Inst. Monogr. 2000 27 95 112
152. C. L. Hayes D. C. Spink B. C. Spink J. Q. Cao N. Walker T. R. Sutter 17b-estradiol hydroxylation catalyzed by human cytochrome P450 1B1 Proc. Natl. Acad. Sci. U. S. A. 1996 93 9776 9781
153. M. S. Denison A. A. Soshilov G. He D. E. DeGroot B. Zhao Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor Toxicol. Sci. 2011 124 1 22
154. Y. Tsuchiya M. Nakajima S. Kyo T. Kanaya M. Inoue T. Yokoi Human CYP1B1 is regulated by estradiol via estrogen receptor Cancer Res. 2004 64 3119 3125
155. M. B. van Duursen J. T. Sanderson M. van der Bruggen J. van der Linden M. van den Berg Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines Toxicol. Appl. Pharmacol. 2003 190 241 250
156. A. Jeuken B. J. G. Keser E. Khan A. Brouwer J. Koeman M. S. Denison Activation of the Ah Receptor by Extracts of Dietary Herbal Supplements, Vegetables, and Fruits J. Agric. Food Chem. 2003 51 5478 5487
157. S. Medjakovic A. Jungbauer Red clover isoflavones biochanin A and formononetin are potent ligands of the human aryl hydrocarbon receptor J. Steroid Biochem. Mol. Biol. 2008 108 171 177
158. A. Mohammadi-Bardbori J. Bengtsson U. Rannug A. Rannug E. Wincent Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR) Chem. Res. Toxicol. 2012 25 1878 1884
159. S. Zhang C. Qin S. H. Safe Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context Environ. Health Perspect. 2003 111 1877 1882
160. S. M. Mense J. Chhabra H. K. Bhat Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin J. Steroid Biochem. Mol. Biol. 2008 110 157 162
161. H. P. Ciolino P. J. Daschner G. C. Yeh Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially Biochem. J. 1999 340 Pt 3 715 722
162. E. H. Han J. Y. Kim H. G. Jeong Effect of biochanin A on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells Arch. Pharmacal Res. 2006 29 570 576
163. P. Gong Z. Madak-Erdogan J. A. Flaws D. J. Shapiro J. A. Katzenellenbogen B. S. Katzenellenbogen Estrogen receptor-alpha and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells Mol. Cell. Endocrinol. 2016 437 190 200
164. P. Tarnow T. Tralau D. Hunecke A. Luch Effects of triclocarban on the transcription of estrogen, androgen and aryl hydrocarbon receptor responsive genes in human breast cancer cells Toxicol. in Vitro 2013 27 1467 1475
165. J. Wagner L. Jiang L. Lehmann Phytoestrogens modulate the expression of 17alpha-estradiol metabolizing enzymes in cultured MCF-7 cells Adv. Exp. Med. Biol. 2008 617 625 632
166. E. L. Cavalieri D. E. Stack P. D. Devanesan R. Todorovic I. Dwivedy S. Higginbotham S. L. Johansson K. D. Patil M. L. Gross J. K. Gooden R. Ramanathan R. L. Cerny E. G. Rogan Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. U. S. A. 1997 94 10937 10942
167. E. Cavalieri K. Frenkel J. G. Liehr E. Rogan D. Roy Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 2000 27 75 93
168. J. D. Yager Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 2000 27 67 73
169. J. G. Liehr Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. Eur. J. Cancer Prev. 1997 6 3 10
170. K. Cao D. E. Stack R. Ramanathan M. L. Gross E. G. Rogan E. L. Cavalieri Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione Chem. Res. Toxicol. 1998 11 909 916
171. H. Takemura T. Itoh K. Yamamoto H. Sakakibara K. Shimoi Selective inhibition of methoxyflavonoids on human CYP1B1 activity Bioorg. Med. Chem. 2010 18 6310 6315
172. T. Shimada K. Tanaka S. Takenaka N. Murayama M. V. Martin M. K. Foroozesh H. Yamazaki F. P. Guengerich M. Komori Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives Chem. Res. Toxicol. 2010 23 1921 1935
173. A. Chaudhary K. L. Willett Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort Toxicology 2006 217 194 205
174. Z. H. Chen Y. J. Hurh H. K. Na J. H. Kim Y. J. Chun D. H. Kim K. S. Kang M. H. Cho Y. J. Surh Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells Carcinogenesis 2004 25 2005 2013
175. Y. J. Chun M. Y. Kim F. P. Guengerich Resveratrol is a selective human cytochrome P450 1A1 inhibitor Biochem. Biophys. Res. Commun. 1999 262 20 24
176. F. Lu M. Zahid C. Wang M. Saeed E. L. Cavalieri E. G. Rogan Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells Cancer Prev. Res. 2008 1 135 145
177. B. Licznerska H. Szaefer M. Wierzchowski H. Sobierajska W. Baer-Dubowska Resveratrol and its methoxy derivatives modulate the expression of estrogen metabolism enzymes in breast epithelial cells by AhR down-regulation Mol. Cell. Biochem. 2016 425 169 179
178. D. Schwarz P. Kisselev W. H. Schunck I. Roots Inhibition of 17beta-estradiol activation by CYP1A1: genotype- and regioselective inhibition by St. John's Wort and several natural polyphenols Biochim. Biophys. Acta 2011 1814 168 174
179. P. Madhubhani L. P. Hemachandra P. Esala R. Chandrasena S. N. Chen M. Main D. C. Lankin R. A. Scism B. M. Dietz G. F. Pauli G. R. Thatcher J. L. Bolton Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A) Cancer Prev. Res. 2012 5 73 81
180. S. Wang T. L. Dunlap C. E. Howell O. C. Mbachu E. A. Rue R. Phansalkar S. N. Chen G. F. Pauli B. M. Dietz J. L. Bolton Hop (Humulus lupulus L.) Extract and 6-Prenylnaringenin Induce P450 1A1 Catalyzed Estrogen 2-Hydroxylation Chem. Res. Toxicol. 2016 29 1142 1150
181. M. B. M. van Duursen J. T. Sanderson P. de Jong M. Kraaij M. van den Berg Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogens induced DNA damage Toxicol. Sci. 2004 81 316 324
182. D. Chen C. Y. Wang J. D. Lambert N. Ai W. J. Welsh C. S. Yang Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies Biochem. Pharmacol. 2005 69 1523 1531
183. L. Lehmann L. Jiang J. Wagner Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells Carcinogenesis 2008 29 363 370
184. M. Zahid N. W. Gaikwad M. F. Ali F. Lu M. Saeed L. Yang E. G. Rogan E. L. Cavalieri Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol Free Radical Biol. Med. 2008 45 136 145
185. T. Key P. Appleby I. Barnes G. Reeves H. Endogenous G. Breast Cancer Collaborative Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J. Natl. Cancer Inst. 2002 94 606 616
186. J. N. Ingle Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings Clin. Cancer Res. 2005 11 900s 905s
187. N. B. Kumar A. Cantor K. Allen D. Riccardi C. E. Cox The specific role of isoflavones on estrogen metabolism in premenopausal women Cancer 2002 94 1166 1174
188. L. Hooper J. J. Ryder M. S. Kurzer J. W. Lampe M. J. Messina W. R. Phipps A. Cassidy Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis Hum. Reprod. Update 2009 15 423 440
189. J. C. Vanegas M. C. Afeiche A. J. Gaskins L. Minguez-Alarcon P. L. Williams D. L. Wright T. L. Toth R. Hauser J. E. Chavarro Soy food intake and treatment outcomes of women undergoing assisted reproductive technology Fertil. Steril. 2015 103 749 755 e742
190. V. Unfer M. L. Casini S. Gerli L. Costabile M. Mignosa G. C. Di Renzo Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial Fertil. Steril. 2004 82 1509 1513
191. K. A. Solak R. R. Santos M. van den Berg B. J. Blaauboer B. A. Roelen M. B. van Duursen Naringenin (NAR) and 8-prenylnaringenin (8-PN) reduce the developmental competence of porcine oocytes in vitro Reprod. Toxicol. 2014 49 1 11
192. W. H. Chan Impact of genistein on maturation of mouse oocytes, fertilization, and fetal development Reprod. Toxicol. 2009 28 52 58
193. S. Mahalingam L. Gao M. Gonnering W. Helferich J. A. Flaws Equol inhibits growth, induces atresia, and inhibits steroidogenesis of mouse antral follicles in vitro Toxicol. Appl. Pharmacol. 2016 295 47 55
194. A. Revelli L. Delle Piane S. Casano E. Molinari M. Massobrio P. Rinaudo Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics Reprod. Biol. Endocrinol. 2009 7 40
195. F. Chen C. Spiessens T. D'Hooghe K. Peeraer S. Carpentier Follicular fluid biomarkers for human in vitro fertilization outcome: Proof of principle Proteome Sci. 2016 14 17
196. V. L. Nelson R. S. Legro J. F. Strauss 3rd J. M. McAllister Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries Mol. Endocrinol. 1999 13 946 957
197. J. C. Rijk A. A. Peijnenburg M. H. Blokland A. Lommen R. L. Hoogenboom T. F. Bovee Screening for Modulatory Effects on Steroidogenesis Using the Human H295R Adrenocortical Cell Line: A Metabolomics Approach Chem. Res. Toxicol. 2012 25 1720 1731
198. T. Strowitzki A. Germeyer R. Popovici M. von Wolff The human endometrium as a fertility-determining factor Hum. Reprod. Update 2006 12 617 630
199. H. Sasano T. Suzuki T. Nakata T. Moriya New development in intracrinology of breast carcinoma Breast Cancer 2006 13 129 136
200. C. A. Piccinato R. M. Neme N. Torres L. R. Sanches P. B. Derogis H. F. Brudniewski J. C. Rosa e Silva R. A. Ferriani Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells J. Steroid Biochem. Mol. Biol. 2016 158 117 126
201. X. Ren X. Wu S. G. Hillier K. S. Fegan H. O. Critchley J. I. Mason S. Sarvi C. R. Harlow Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy J. Steroid Biochem. Mol. Biol. 2015 150 54 63
202. S. P. Myers V. Vigar Effects of a standardised extract of Trifolium pratense (Promensil) at a dosage of 80 mg in the treatment of menopausal hot flushes: A systematic review and meta-analysis Phytomedicine 2017 24 141 147
203. C. B. Tempfer G. Froese G. Heinze E. K. Bentz L. A. Hefler J. C. Huber Side effects of phytoestrogens: a meta-analysis of randomized trials Am. J. Med. 2009 122 939 946 e939
204. A. M. Quaas N. Kono W. J. Mack H. N. Hodis J. C. Felix R. J. Paulson D. Shoupe Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial Menopause 2013 20 840 844
205. EFSA Panel on Food Additives and Nutrient Sources added to Food Scientific opinion on the risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones EFSA J. 2015 13 4246
206. F. P. van Hunsel P. Kampschoer [Postmenopausal bleeding and dietary supplements: a possible causal relationship with hop- and soy-containing preparations] Ned. Tijdschr. Geneeskd. 2012 156 A5095
207. A. Chandrareddy O. Muneyyirci-Delale S. I. McFarlane O. M. Murad Adverse effects of phytoestrogens on reproductive health: a report of three cases Complement. Ther. Clin. Pract. 2008 14 132 135
208. P. J. Magee I. Rowland Soy products in the management of breast cancer Curr. Opin. Clin. Nutr. Metab. Care 2012 15 586 591
209. M. Du X. Yang J. A. Hartman P. S. Cooke D. R. Doerge Y. H. Ju W. G. Helferich Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice Carcinogenesis 2012 33 895 901
210. Y. H. Ju D. R. Doerge K. A. Woodling J. A. Hartman J. Kwak W. G. Helferich Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo Carcinogenesis 2008 29 2162 2168
211. M. Bryant A. Cassidy C. Hill J. Powell D. Talbot L. Dye Effect of consumption of soy isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome Br. J. Nutr. 2005 93 731 739
212. B. E. Burke R. D. Olson B. J. Cusack Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine Biomed. Pharmacother. 2002 56 283 288
213. M. Messina Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature Nutrients 2016 8 12 pii: E754